The SLC10A1 gene gives liver cells instructions for a protein that pulls bile acids, which help digest fats, out of the blood and into the liver. This gene plays an important role in this recycling process, and if it does not work well, bile acids can build up in the blood and may cause jaundice, itching, or unusual liver test results. The same protein is also used by hepatitis B and hepatitis D viruses to enter liver cells, so some variants can influence infection risk.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mostly regulate when specific processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how your body grows and works, and they can influence how you respond to food, stress, and medications. For a more in depth look at this topic, you can find additional information in the LearnHub.
Overview
SLC10A1Gene function
What if the gene works
The SLC10A1 gene helps liver cells take bile acids back up from the blood. This supports bile recycling, which helps your body digest and absorb fats.
Risk
What if the gene does not work
Variants in the SLC10A1 gene can reduce the liver’s uptake of bile acids. This is best known for causing NTCP deficiency, often with high blood bile acids and sometimes mild jaundice or itching; milder and more severe variants can differ.
Treatment
What does that mean for your treatment
No treatment or drug choice tied specifically to pathogenic variants in the SLC10A1 gene is currently established in clinical guidelines. The SLC10A1 gene is a drug target in hepatitis research and treatment because its protein helps hepatitis B and D viruses enter liver cells, and bulevirtide blocks this step.
Conditions associated with SLC10A1
Gene function
What if the gene works
In the liver, the SLC10A1 gene helps handle bile acids, which are natural compounds that help digest fats. Its protein sits on the blood facing surface of liver cells and brings these compounds inside for reuse. Understanding how the SLC10A1 gene works can make it easier to see how digestion and bile recycling stay on track day to day.
The SLC10A1 gene makes a transporter on the blood facing side of liver cells. It uses sodium to move bile acids from blood coming from the gut into the cell.
This uptake returns bile acids to the liver after the intestine has used them for digestion. It supports the normal recycling loop that lets your body reuse these compounds many times.
By clearing bile acids from incoming blood, this gene helps keep their levels in a healthy range. That steady handling supports routine liver work from one meal to the next.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect at all and simply represent natural genetic variation. In some situations, though, a variant can change gene function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC10A1 gene can alter how the NTCP protein folds, reaches the liver cell surface, or transports bile acids, which is how SLC10A1 gene variants affect protein function. Some variants leave partial activity, while more disruptive variants can greatly reduce or nearly stop transport. When both gene copies carry stronger variants, NTCP deficiency often has a larger functional effect and may be linked to earlier or more noticeable changes in bile acid levels.
How variants are linked to conditions
Pathogenic variants in both copies of the SLC10A1 gene cause NTCP deficiency, also called SLC10A1-related hypercholanemia. People with this condition have persistently high bile acid levels on blood tests and may have newborn jaundice, itching, or mild liver test changes, although some feel well. Research also suggests some common variants in the SLC10A1 gene may influence hepatitis B infection risk in some populations, but these findings do not by themselves diagnose liver disease.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural differences among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the SLC10A1 gene. If a change in SLC10A1 is found, its effects can vary from one person to another, and discussing personal risk with a doctor or genetic counselor can help put the result in context.
Inheritance of SLC10A1 variants
SLC10A1-related hypercholanemia is inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing variants in the SLC10A1 gene, one from each parent. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child. For families asking how SLC10A1 gene variants are inherited, sons and daughters are affected at the same rate because this gene is on chromosome 14.
What does my SLC10A1 result mean for my family?
For families with a disease-causing SLC10A1 change, the pattern is recessive, which usually means parents are healthy carriers and brothers or sisters could also have the condition or be carriers. Close relatives may want to learn whether the same gene change is present, especially if there is a history of high bile acids or related liver findings in the family. The main family impact is often carrier status rather than illness in adults.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the SLC10A1 gene uses a blood, saliva, or cheek swab sample. A lab reads the DNA in this gene and looks for changes that may explain a health finding or show whether you carry a known family variant.
When should I consider getting a genetic test?
Genetic testing for the SLC10A1 gene may be considered when someone has persistently high levels of bile acids, the digestive chemicals made by the liver, or unexplained jaundice and other liver-related findings starting early in life. It can also help when similar problems are seen in close relatives.
A genetic result is only one part of your health story
Genetic test results can be informative, but what they reveal depends on the condition and the specific type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, moves, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. These inherited differences are common and can influence both how well a medicine helps and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the SLC10A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about side effects, liver-related symptoms, or medicines are best discussed with your doctor. SLC10A1 has been studied because it helps move bile acids and some medicines into the liver, but this research is not used routinely to decide treatment.
History
The SLC10A1 gene entered medical research through studies of how the liver takes up substances from the blood. It was first identified as the gene for a liver transport protein, which gave researchers a clearer map of bile handling in the body. From these first observations, research expanded steadily. A major turning point came when scientists showed that this same protein also serves as an entry point for hepatitis B and hepatitis D viruses into liver cells. That finding connected liver transport research with infectious disease in a new way and made the SLC10A1 gene much more important in hepatitis research. Today, its history reflects how one gene can link basic biology with major clinical questions.